Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma × Proton Therapy × Clear all

Phase

Phase NA 4 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Glioma 2 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrent Head and Neck Carcinoma 1 Radiation Injuries 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Meningioma 1 Gliosarcoma 1 Eye Neoplasms 1 Esophageal Neoplasms 1 Ependymoma 1 Desmoplastic Small Round Cell Tumor 1 Craniopharyngioma 1 Chordoma 1 Chondrosarcoma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Doxorubicin 52 Ifosfamide 32 Gemcitabine 25 Radiotherapy 21 Filgrastim 21 Cyclophosphamide 21 Docetaxel 17 Vincristine 15 Etoposide 15 Trabectedin 14 Nivolumab 14 pembrolizumab 12 pazopanib 12 apatinib 12 Cisplatin 12 Magnetic Resonance Spectroscopy 11 Sirolimus 10 Irinotecan 10 Carboplatin 10 Temozolomide 9 Surgical Procedures, Operative 9 Sorafenib 9 anlotinib 8 Ipilimumab 8 Dactinomycin 8 Bevacizumab 8 Topotecan 7 Paclitaxel 7 palbociclib 6 camrelizumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00881595 2017-02-10

SA02

University of Florida

Phase 2 Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡